Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner

BACKGROUND: In recent years, peroxisome proliferator-activated receptor γ (PPARγ) has been found to be closely associated with hypoxia renal disease. The aim of this study was to investigate the relationship between rosiglitazone and mitochondrial apoptosis in renal tissue and its associated mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jun-Yu, Hu, Miao-Yue, Chen, Xiu-Qi, Lei, Feng-Ying, Wei, Jin-Shuang, Chen, Jie, Qin, Xuan-Kai, Qin, Yuan-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704099/
https://www.ncbi.nlm.nih.gov/pubmed/36420656
http://dx.doi.org/10.1080/0886022X.2022.2148539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704099/
https://www.ncbi.nlm.nih.gov/pubmed/36420656
http://dx.doi.org/10.1080/0886022X.2022.2148539

Ejemplares similares